{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T08:57:58Z","timestamp":1758272278057,"version":"3.44.0"},"reference-count":133,"publisher":"Elsevier","isbn-type":[{"type":"print","value":"9780128196663"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1016\/b978-0-12-819666-3.00005-5","type":"book-chapter","created":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T13:05:58Z","timestamp":1586523958000},"page":"141-182","source":"Crossref","is-referenced-by-count":2,"title":["Tailoring drug and gene codelivery nanosystems for glioblastoma treatment"],"prefix":"10.1016","author":[{"given":"Jessica","family":"Silva","sequence":"first","affiliation":[]},{"given":"Jo\u00e3o","family":"Basso","sequence":"additional","affiliation":[]},{"given":"Maria","family":"Mendes","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o","family":"Sousa","sequence":"additional","affiliation":[]},{"given":"Alberto","family":"Pais","sequence":"additional","affiliation":[]},{"given":"Carla","family":"Vitorino","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib1","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.addr.2009.03.010","article-title":"Effects of nanomaterial physicochemical properties on in vivo toxicity","volume":"61","author":"Aillon","year":"2009","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib2","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ejps.2010.05.003","article-title":"Strategy for effective brain drug delivery","volume":"40","author":"Alam","year":"2010","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib3","doi-asserted-by":"crossref","first-page":"230","DOI":"10.2478\/romneu-2018-0030","article-title":"Metformin delivery using chitosan-capped gold nanoparticles in glioblastoma cell lines","volume":"32","author":"Aldea","year":"2018","journal-title":"Roman. Neurosurg."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib4","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ijpharm.2012.06.025","article-title":"Drug delivery strategies for the treatment of malignant gliomas","volume":"436","author":"Allhenn","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib5","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1021\/acs.molpharmaceut.5b00694","article-title":"Nanoparticle-delivered antisense MicroRNA-21 enhances the effects of temozolomide on glioblastoma cells","volume":"12","author":"Ananta","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib6","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1021\/acs.molpharmaceut.6b00388","article-title":"Tailored nanoparticle codelivery of antimiR-21 and antimiR-10b augments glioblastoma cell kill by temozolomide: toward a \u201cpersonalized\u201d anti-microRNA therapy","volume":"13","author":"Ananta","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib7","doi-asserted-by":"crossref","first-page":"5003","DOI":"10.1073\/pnas.1019055108","article-title":"Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma","volume":"108","author":"Arroyo","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib8","doi-asserted-by":"crossref","first-page":"6687","DOI":"10.18632\/oncotarget.2235","article-title":"Systemic miRNA-7 delivery inhibits tumor angiogenesis and growth in murine xenograft glioblastoma","volume":"5","author":"Babae","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib9","first-page":"9","article-title":"Emerging microRNA therapeutic approaches for cystic fibrosis","author":"Bardin","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib10","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib11","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3390\/gels4030062","article-title":"Hydrogel-based drug delivery nanosystems for the treatment of brain tumors","volume":"4","author":"Basso","year":"2018","journal-title":"Gels"},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib12","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.canlet.2018.04.039","article-title":"Repurposing drugs for glioblastoma: from bench to bedside","volume":"428","author":"Basso","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib13","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jconrel.2017.04.006","article-title":"Design of Y-shaped targeting material for liposome-based multifunctional glioblastoma-targeted drug delivery","volume":"255","author":"Belhadj","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib14","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1039\/C3MD00314K","article-title":"Pre-miRNA expressing plasmid delivery for anti-cancer therapy","volume":"5","author":"Benisvy-Aharonovich","year":"2014","journal-title":"MedChemComm"},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib15","first-page":"306","article-title":"Development and characterization of cationic solid lipid nanoparticles for co-delivery of pemetrexed and miR-21 antisense oligonucleotide to glioblastoma cells","volume":"44","author":"Berrin","year":"2017","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib16","doi-asserted-by":"crossref","first-page":"5687","DOI":"10.1002\/smll.201500540","article-title":"Combined delivery of temozolomide and anti-miR221 PNA using mesoporous silica nanoparticles induces apoptosis in resistant glioma cells","volume":"11","author":"Bertucci","year":"2015","journal-title":"Small"},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib17","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/gt.2011.50","article-title":"MicroRNA therapeutics","volume":"18","author":"Broderick","year":"2011","journal-title":"Gene Ther."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib18","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.3892\/or.2014.3012","article-title":"A lentivirus-mediated miR-23b sponge diminishes the malignant phenotype of glioma cells in vitro and in vivo","volume":"31","author":"Chen","year":"2014","journal-title":"Oncol. Rep."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib19","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.addr.2014.05.009","article-title":"In vivo delivery of miRNAs for cancer therapy: challenges and strategies","volume":"81","author":"Chen","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib20","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.ejpb.2014.10.017","article-title":"Positive-charged solid lipid nanoparticles as paclitaxel drug delivery system in glioblastoma treatment","volume":"88","author":"Chirio","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib21","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.nano.2018.01.021","article-title":"Enhancing glioblastoma treatment using cisplatin-gold-nanoparticle conjugates and targeted delivery with magnetic resonance-guided focused ultrasound","volume":"14","author":"Coluccia","year":"2018","journal-title":"Nanomedicine"},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib22","doi-asserted-by":"crossref","first-page":"5118","DOI":"10.1093\/hmg\/dds358","article-title":"PDGF-B-mediated downregulation of miR-21: new insights into PDGF signaling in glioblastoma","volume":"21","author":"Costa","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib23","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1038\/mtna.2013.30","article-title":"Tumor-targeted chlorotoxin-coupled nanoparticles for nucleic acid delivery to glioblastoma cells: a promising system for glioblastoma treatment","volume":"2","author":"Costa","year":"2013","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jconrel.2015.04.002","article-title":"MiRNA-21 silencing mediated by tumor-targeted nanoparticles combined with sunitinib: a new multimodal gene therapy approach for glioblastoma","volume":"207","author":"Costa","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib25","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.3390\/ph6111361","article-title":"Nanoparticles as drug delivery systems in cancer medicine: emphasis on RNAi-containing nanoliposomes","volume":"6","author":"D\u00edaz","year":"2013","journal-title":"Pharmaceuticals"},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib26","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13046-015-0216-8","article-title":"Dual loading miR-218 mimics and Temozolomide using AuCOOH@ FA-CS drug delivery system: promising targeted anti-tumor drug delivery system with sequential release functions","volume":"34","author":"Fan","year":"2015","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib27","doi-asserted-by":"crossref","first-page":"e18067","DOI":"10.1371\/journal.pone.0018067","article-title":"The impact of miRNA target sites in coding sequences and in 3\u2032 UTRs","volume":"6","author":"Fang","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib28","doi-asserted-by":"crossref","first-page":"6674","DOI":"10.1021\/am5092165","article-title":"Temozolomide nanoparticles for targeted glioblastoma therapy","volume":"7","author":"Fang","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib29","first-page":"186","article-title":"Epithelial-mesenchymal transition (EMT): principles and clinical impact in cancer therapy","volume":"54","author":"Franco-Chuaire","year":"2013","journal-title":"Invest. Clin."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib30","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jconrel.2013.08.020","article-title":"Targeting by cmHsp70.1-antibody coated and survivin miRNA plasmid loaded nanoparticles to radiosensitize glioblastoma cells","volume":"172","author":"Gaca","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib31","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1080\/1061186X.2019.1567738","article-title":"Paclitaxel-loaded multifunctional nanoparticles for the targeted treatment of glioblastoma","volume":"27","author":"Ganipineni","year":"2019","journal-title":"J. Drug Target"},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib32","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.addr.2015.01.008","article-title":"Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides","volume":"87","author":"Geary","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib33","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.ijpharm.2013.05.049","article-title":"Silencing of miR-21 by locked nucleic acid-lipid nanocapsule complexes sensitize human glioblastoma cells to radiation-induced cell death","volume":"454","author":"Griveau","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib34","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrm3838","article-title":"Regulation of microRNA biogenesis","volume":"15","author":"Ha","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib35","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11060-013-1155-x","article-title":"MicroRNA biomarkers in glioblastoma","volume":"114","author":"Hermansen","year":"2013","journal-title":"J. Neurooncol."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib36","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.2174\/1381612822666151221150733","article-title":"Evolving drug delivery strategies to overcome the blood brain barrier","volume":"22","author":"Hersh","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib37","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3109\/07357907.2012.708071","article-title":"Plasma MicroRNA-21 concentration may be a useful biomarker in glioblastoma patients","volume":"30","author":"Ilhan-Mutlu","year":"2012","journal-title":"Cancer Invest."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib38","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201707779","article-title":"MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review","volume":"9","author":"Iorio","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib39","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1039\/C1NJ20489K","article-title":"Cytotoxicity of PAMAM, PPI and maltose modified PPI dendrimers in Chinese hamster ovary (CHO) and human ovarian carcinoma (SKOV3) cells","volume":"36","author":"Janaszewska","year":"2012","journal-title":"N. J. Chem."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib40","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2353\/ajpath.2010.090812","article-title":"miR-182 as a prognostic marker for glioma progression and patient survival","volume":"177","author":"Jiang","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib41","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ejpb.2018.09.012","article-title":"Design of multifunctional peptide collaborated and docetaxel loaded lipid nanoparticles for antiglioma therapy","volume":"132","author":"Kadari","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib42","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.canlet.2013.02.019","article-title":"Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growth","volume":"335","author":"Katakowski","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib43","doi-asserted-by":"crossref","first-page":"6867","DOI":"10.1016\/j.biomaterials.2010.05.027","article-title":"The systemic toxicity of positively charged lipid nanoparticles and the role of Toll-like receptor 4 in immune activation","volume":"31","author":"Kedmi","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib44","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1021\/acs.bioconjchem.5b00146","article-title":"Co-delivery of protein and small molecule therapeutics using nanoparticle-stabilized nanocapsules","volume":"26","author":"Kim","year":"2015","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib45","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1074\/jbc.M111.288662","article-title":"Competitive interactions of cancer cells and normal cells via secretory microRNAs","volume":"287","author":"Kosaka","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib46","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1101\/gad.257394.114","article-title":"miR-182 integrates apoptosis, growth, and differentiation programs in glioblastoma","volume":"29","author":"Kouri","year":"2015","journal-title":"Genes Dev."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib47","doi-asserted-by":"crossref","first-page":"D155","DOI":"10.1093\/nar\/gky1141","article-title":"miRBase: from microRNA sequences to function","volume":"47","author":"Kozomara","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib48","first-page":"1","article-title":"Co-delivery of pemetrexed and miR-21 antisense oligonucleotide by lipid-polymer hybrid nanoparticles and effects on glioblastoma cells","volume":"9045","author":"K\u00fc\u00e7\u00fckt\u00fcrkmen","year":"2016","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib49","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.colsurfb.2011.02.011","article-title":"Catanionic solid lipid nanoparticles carrying doxorubicin for inhibiting the growth of U87MG cells","volume":"85","author":"Kuo","year":"2011","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib50","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1002\/jps.24388","article-title":"Inhibition against growth of glioblastoma multiforme in vitro using etoposide-loaded solid lipid nanoparticles with p-aminophenyl-\u03b1-d-manno-pyranoside and folic acid","volume":"104","author":"Kuo","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jtice.2014.08.035","article-title":"Delivery of doxorubicin to glioblastoma multiforme in vitro using solid lipid nanoparticles with surface aprotinin and melanotransferrin antibody for enhanced chemotherapy","volume":"000","author":"Kuo","year":"2015","journal-title":"J. Taiwan Inst. Chem. E"},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib52","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.3390\/cancers5041271","article-title":"Strategies in gene therapy for glioblastoma","volume":"5","author":"Kwiatkowska","year":"2013","journal-title":"Cancers"},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib53","doi-asserted-by":"crossref","first-page":"4482","DOI":"10.1200\/JCO.2010.33.8715","article-title":"Evidence for sequenced molecular evolution of IDH1 mutant glioblastoma from a distinct cell of origin","volume":"29","author":"Lai","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib54","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.colsurfb.2018.09.047","article-title":"Co-delivery of doxorubicin and erlotinib through liposomal nanoparticles for glioblastoma tumor regression using an in vitro brain tumor model","volume":"173","author":"Lakkadwala","year":"2019","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib55","doi-asserted-by":"crossref","first-page":"e36248","DOI":"10.1371\/journal.pone.0036248","article-title":"Genome-wide profiling identified a set of miRNAs that are differentially expressed in glioblastoma stem cells and normal neural stem cells","volume":"7","author":"Lang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib56","doi-asserted-by":"crossref","first-page":"346","DOI":"10.18632\/oncotarget.868","article-title":"Mesenchymal stem cells deliver synthetic microRNA mimics to glioma cells and glioma stem cells and inhibit their cell migration and self-renewal","volume":"4","author":"Lee","year":"2013","journal-title":"Oncotarget"},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib57","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-Y","article-title":"The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14","volume":"75","author":"Lee","year":"1993","journal-title":"Cell"},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib58","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/j.ymthe.2016.11.016","article-title":"RNA nanoparticle-based targeted therapy for glioblastoma through inhibition of oncogenic miR-21","volume":"25","author":"Lee","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib59","first-page":"27","article-title":"Downregulation of ABCG2 expression in glioblastoma cancer stem cells with miRNA-328 may decrease their chemoresistance","volume":"16","author":"Li","year":"2010","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib60","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nrc3932","article-title":"MicroRNA biogenesis pathways in cancer","volume":"15","author":"Lin","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib61","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1083\/jcb.201208082","article-title":"Discovering the first microRNA-targeted drug","volume":"199","author":"Lindow","year":"2012","journal-title":"J. Cell Biol."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib62","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.3892\/or.2013.2283","article-title":"Poly(amido amine) is an ideal carrier of miR-7 for enhancing gene silencing effects on the EGFR pathway in U251 glioma cells","volume":"29","author":"Liu","year":"2013","journal-title":"Oncol. Rep."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib63","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.carbpol.2019.02.084","article-title":"Preparation, characterisation and in vitro and in vivo evaluation of CD44-targeted chondroitin sulphate-conjugated doxorubicin PLGA nanoparticles","volume":"213","author":"Liu","year":"2019","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib64","doi-asserted-by":"crossref","first-page":"8554","DOI":"10.1039\/C5NR01404B","article-title":"Chondroitin sulfate-polyethylenimine copolymer-coated superparamagnetic iron oxide nanoparticles as an efficient magneto-gene carrier for microRNA-encoding plasmid DNA delivery","volume":"7","author":"Lo","year":"2015","journal-title":"Nanoscale"},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib65","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1021\/acs.nanolett.8b00390","article-title":"Bioreducible polymeric nanoparticles containing multiplexed cancer stem cell regulating miRNAs inhibit glioblastoma growth and prolong survival","volume":"18","author":"Lopez-Bertoni","year":"2018","journal-title":"Nano Lett."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib66","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization classification of tumors of the central nervous system: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib67","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nature03702","article-title":"MicroRNA expression profiles classify human cancers","volume":"435","author":"Lu","year":"2005","journal-title":"Nature"},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib68","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s11060-011-0575-8","article-title":"The natural history of extracranial metastasis from glioblastoma multiforme","volume":"105","author":"Lun","year":"2011","journal-title":"J. Neurooncol."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib69","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.nano.2012.10.003","article-title":"Poly (ethylene)-glycol conjugated solid lipid nanoparticles of noscapine improve biological half-life, brain delivery and efficacy in glioblastoma cells","volume":"9","author":"Madan","year":"2013","journal-title":"Nanomedicine"},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib70","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.3109\/10717544.2014.975382","article-title":"Curcumin-loaded nanostructured lipid carriers (NLCs) for nasal administration: design, characterization, and in vivo study","volume":"23","author":"Madane","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib71","doi-asserted-by":"crossref","first-page":"21478","DOI":"10.18632\/oncotarget.25135","article-title":"Targeted nanoparticle delivery of therapeutic antisense microRNAs presensitizes glioblastoma cells to lower effective doses of temozolomide in vitro and in a mouse model","volume":"9","author":"Malhotra","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib72","doi-asserted-by":"crossref","first-page":"21478","DOI":"10.18632\/oncotarget.25135","article-title":"Targeted nanoparticle delivery of therapeutic antisense microRNAs presensitizes glioblastoma cells to lower effective doses of temozolomide in vitro and in a mouse model","volume":"9","author":"Malhotra","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib73","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ijpharm.2017.03.049","article-title":"Delivery of doxorubicin-loaded PLGA nanoparticles into U87 human glioblastoma cells","volume":"524","author":"Malinovskaya","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib74","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1750-3639.2009.00328.x","article-title":"Identification and functional characterization of microRNAs involved in the malignant progression of gliomas","volume":"20","author":"Malzkorn","year":"2010","journal-title":"Brain Pathol."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib75","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.biocel.2019.01.010","article-title":"Tri-block copolymer nanoparticles modified with folic acid for temozolomide delivery in glioblastoma","volume":"108","author":"Minaei","year":"2019","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib76","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.biocel.2019.01.010","article-title":"Tri-block copolymer nanoparticles modified with folic acid for temozolomide delivery in glioblastoma","volume":"108","author":"Minaei","year":"2019","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib77","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.msec.2019.04.007","article-title":"In vitro anti-cancer efficacy of multi-functionalized magnetite nanoparticles combining alternating magnetic hyperthermia in glioblastoma cancer cells","volume":"101","author":"Minaei","year":"2019","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib78","first-page":"403","article-title":"Dendrosomal curcumin nanoformulation downregulates pluripotency genes via miR-145 activation in U87MG glioblastoma cells","volume":"9","author":"Mirgani","year":"2014","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib79","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s12035-012-8349-7","article-title":"A systematic review of microRNA in glioblastoma multiforme: micro-modulators in the mesenchymal mode of migration and invasion","volume":"47","author":"Moller","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib80","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jsps.2011.04.001","article-title":"Nanoparticles: emerging carriers for drug delivery","volume":"19","author":"Mudshinge","year":"2011","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib81","doi-asserted-by":"crossref","first-page":"e126","DOI":"10.1038\/mtna.2013.60","article-title":"Delivery of functional anti-miR-9 by mesenchymal stem cell-derived exosomes to glioblastoma multiforme cells conferred chemosensitivity","volume":"2","author":"Munoz","year":"2013","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib82","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1186\/s13059-014-0445-8","article-title":"MicroRNA regulation of tumorigenesis, cancer progression and interpatient heterogeneity: towards clinical use","volume":"15","author":"Nana-Sinkam","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib83","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1016\/j.nano.2016.05.016","article-title":"Restoring the oncosuppressor activity of microRNA-34a in glioblastoma using a polyglycerol-based polyplex","volume":"12","author":"Ofek","year":"2016","journal-title":"Nanomedicine"},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib84","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/bpa.12328","article-title":"Genetic alterations in gliosarcoma and giant cell glioblastoma","volume":"26","author":"Oh","year":"2016","journal-title":"Brain Pathol."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib85","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/jnen\/64.6.479","article-title":"Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas","volume":"64","author":"Ohgaki","year":"2005","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib86","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1158\/1078-0432.CCR-12-3002","article-title":"The definition of primary and secondary glioblastoma","volume":"19","author":"Ohgaki","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib87","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/nou223","article-title":"CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007\u20132011","volume":"16","author":"Ostrom","year":"2014","journal-title":"Neuro Oncol."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib88","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1128\/MCB.00443-12","article-title":"Heterogeneous nuclear ribonucleoprotein C1\/C2 controls the metastatic potential of glioblastoma by regulating PDCD4","volume":"32","author":"Park","year":"2012","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib89","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nrc2966","article-title":"RNA interference in the clinic: challenges and future directions","volume":"11","author":"Pecot","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib90","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ijpharm.2018.11.014","article-title":"Toxicological study of doxorubicin-loaded PLGA nanoparticles for the treatment of glioblastoma","volume":"554","author":"Pereverzeva","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib91","article-title":"A curcumin-loaded polymeric micelle as a carrier of a microRNA-21 antisense-oligonucleotide for enhanced anti-tumor effects in a glioblastoma animal model","volume":"6","author":"Piao","year":"2018","journal-title":"Biomater. Sci."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib92","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/app.37823","article-title":"Synergistic inhibition of human glioma cell line by temozolomide and PAMAM-mediated miR-21i","volume":"127","author":"Qian","year":"2013","journal-title":"J. Appl. Polym. Sci."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib93","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ijpharm.2018.04.062","article-title":"Receptor-mediated PLGA nanoparticles for glioblastoma multiforme treatment","volume":"545","author":"Ramalho","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib94","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1471-4159.2011.07307.x","article-title":"A specific miRNA signature in the peripheral blood of glioblastoma patients","volume":"118","author":"Roth","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib95","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/WNR.0000000000000302","article-title":"Tumor suppressor miR-181c attenuates proliferation, invasion, and self-renewal abilities in glioblastoma","volume":"26","author":"Ruan","year":"2015","journal-title":"Neuroreport"},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib96","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd.2016.246","article-title":"MicroRNA therapeutics: towards a new era for the management of cancer and other diseases","volume":"16","author":"Rupaimoole","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib97","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1158\/2159-8290.CD-15-0893","article-title":"miRNA deregulation in cancer cells and the tumor microenvironment","volume":"6","author":"Rupaimoole","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib98","doi-asserted-by":"crossref","first-page":"5164","DOI":"10.1039\/C4NJ01314J","article-title":"Cationic liposome-nucleic acid complexes for gene delivery and gene silencing","volume":"38","author":"Safinya","year":"2014","journal-title":"N. J. Chem."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib99","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0005-2736(91)90160-A","article-title":"Interaction of positively-charged liposomes with blood: implications for their application in vivo","volume":"1070","author":"Senior","year":"1991","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib100","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.biomaterials.2019.02.016","article-title":"Nanoparticle-mediated intratumoral inhibition of miR-21 for improved survival in glioblastoma","volume":"201","author":"Seo","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib101","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jconrel.2016.08.029","article-title":"Functionalized nanogels carrying an anticancer microRNA for glioblastoma therapy","volume":"239","author":"Shatsberg","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib102","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1002\/cam4.775","article-title":"MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics","volume":"5","author":"Shea","year":"2016","journal-title":"Cancer Med."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib103","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/ncb1800","article-title":"Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers","volume":"10","author":"Skog","year":"2008","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib104","doi-asserted-by":"crossref","first-page":"264","DOI":"10.4149\/neo_2010_03_264","article-title":"MicroRNA-181 family predicts response to concomitant chemoradiotherapy with temozolomide in glioblastoma patients","volume":"57","author":"Slaby","year":"2010","journal-title":"Neoplasma"},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib105","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.3109\/10717544.2015.1064186","article-title":"Novel RGD containing, temozolomide-loading nanostructured lipid carriers for glioblastoma multiforme chemotherapy","volume":"23","author":"Song","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib106","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib107","first-page":"327","article-title":"Overexpressed miRNA-137 inhibits human glioma cells growth by targeting Rac1","volume":"28","author":"Sun","year":"2013","journal-title":"Cancer Biother. Radiopharm."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib108","first-page":"456","article-title":"Serum microRNA-128 as a biomarker for diagnosis of glioma","volume":"8","author":"Sun","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib109","doi-asserted-by":"crossref","first-page":"268","DOI":"10.15252\/emmm.201505495","article-title":"Therapeutic potential of targeting microRNA-10b in established intracranial glioblastoma: first steps toward the clinic","volume":"8","author":"Teplyuk","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib110","doi-asserted-by":"crossref","first-page":"79584","DOI":"10.18632\/oncotarget.12861","article-title":"MicroRNA-101 reverses temozolomide resistance by inhibition of GSK3\u03b2 in glioblastoma","volume":"7","author":"Tian","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib111","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jconrel.2017.03.017","article-title":"MR image-guided delivery of cisplatin-loaded brain-penetrating nanoparticles to invasive glioma with focused ultrasound","volume":"263","author":"Timbie","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib112","doi-asserted-by":"crossref","first-page":"6716","DOI":"10.1038\/ncomms7716","article-title":"Brain metastatic cancer cells release microRNA-181c-containing extracellular vesicles capable of destructing blood\u2013brain barrier","volume":"6","author":"Tominaga","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib113","doi-asserted-by":"crossref","first-page":"7223","DOI":"10.1093\/nar\/gkr254","article-title":"Characterization of extracellular circulating microRNA","volume":"39","author":"Turchinovich","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib114","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.canlet.2010.04.013","article-title":"miR-195, miR-455-3p and miR-10a( *) are implicated in acquired temozolomide resistance in glioblastoma multiforme cells","volume":"296","author":"Ujifuku","year":"2010","journal-title":"Cancer Lett."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib115","first-page":"307","article-title":"Glioblastoma multiforme \u2013 an overview","volume":"18","author":"Urba\u0144ska","year":"2014","journal-title":"Contemp. Oncol."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib116","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3390\/jcm8030367","article-title":"Synergistic action of gefitinib and GSK41364A simultaneously loaded in ratiometrically-engineered polymeric nanoparticles for glioblastoma multiforme","volume":"8","author":"Velpurisiva","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib117","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","article-title":"Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1","volume":"17","author":"Verhaak","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib118","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nm1087","article-title":"Cancer genes and the pathways they control","volume":"10","author":"Vogelstein","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib119","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1756-9966-31-97","article-title":"Plasma specific miRNAs as predictive biomarkers for diagnosis and prognosis of glioma","volume":"31","author":"Wang","year":"2012","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib120","doi-asserted-by":"crossref","first-page":"274","DOI":"10.4149\/neo_2013_036","article-title":"Regulation of epidermal growth factor receptor signaling by plasmid-based microRNA-7 inhibits human malignant gliomas growth and metastasis in vivo","volume":"60","author":"Wang","year":"2013","journal-title":"Neoplasma"},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib121","doi-asserted-by":"crossref","first-page":"12827","DOI":"10.1038\/s41598-018-30072-x","article-title":"Angiopep-2\/IP10-EGFRvIIIscFv modified nanoparticles and CTL synergistically inhibit malignant glioblastoma","volume":"8","author":"Wang","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib122","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jconrel.2015.09.059","article-title":"Liposome-based glioma targeted drug delivery enabled by stable peptide ligands","volume":"218","author":"Wei","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib123","first-page":"372","article-title":"Immune modulatory nanoparticle therapeutics for intracerebral glioma","volume":"19","author":"Yaghi","year":"2017","journal-title":"Neuro Oncol."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib124","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJMoa0808710","article-title":"IDH1 and IDH2 mutations in gliomas","volume":"360","author":"Yan","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib125","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.biomaterials.2011.10.071","article-title":"Inhibition of cancer stem cell-like properties and reduced chemoradioresistance of glioblastoma using microRNA145 with cationic polyurethane-short branch PEI","volume":"33","author":"Yang","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib126","doi-asserted-by":"crossref","first-page":"6534","DOI":"10.1016\/j.biomaterials.2014.04.057","article-title":"Gadolinium-functionalized nanographene oxide for combined drug and microRNA delivery and magnetic resonance imaging","volume":"35","author":"Yang","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib127","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1002\/smll.201400963","article-title":"Combined magnetic nanoparticle-based MicroRNA and hyperthermia therapy to enhance apoptosis in brain cancer cells","volume":"10","author":"Yin","year":"2014","journal-title":"Small"},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib128","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3171\/2015.1.JNS141577","article-title":"Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma","volume":"124","author":"Yue","year":"2016","journal-title":"J. Neurosurg."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ydbio.2006.08.028","article-title":"microRNAs as oncogenes and tumor suppressors","volume":"302","author":"Zhang","year":"2007","journal-title":"Dev. Biol."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib130","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jconrel.2017.03.007","article-title":"Convection enhanced delivery of cisplatin-loaded brain penetrating nanoparticles cures malignant glioma in rats","volume":"263","author":"Zhang","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib131","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1080\/10717544.2017.1344334","article-title":"Dual-modified liposome codelivery of doxorubicin and vincristine improve targeting and therapeutic efficacy of glioma","volume":"24","author":"Zhang","year":"2017","journal-title":"Drug Deliv."},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib132","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jconrel.2014.07.054","article-title":"cRGD-directed, NIR-responsive and robust AuNR\/PEG\u2013PCL hybrid nanoparticles for targeted chemotherapy of glioblastoma in vivo","volume":"195","author":"Zhong","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/B978-0-12-819666-3.00005-5_bib133","first-page":"6713","article-title":"Tumor location and growth pattern correlate with genetic signature in oligodendroglial neoplasms","volume":"61","author":"Zlatescu","year":"2001","journal-title":"Cancer Res."}],"container-title":["Advances and Avenues in the Development of Novel Carriers for Bioactives and Biological Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780128196663000055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780128196663000055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T19:21:55Z","timestamp":1757013715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780128196663000055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9780128196663"],"references-count":133,"URL":"https:\/\/doi.org\/10.1016\/b978-0-12-819666-3.00005-5","relation":{},"subject":[],"published":{"date-parts":[[2020]]}}}